Uracle's consolidated revenue rose from KRW 45.7 billion in 2023 to KRW 47.6 billion in 2024, up 4.0% year on year, and then fell to KRW 43.8 billion in 2025, down 8.0%. Of 2023 to 2025, 2024 was the largest year and 2025 the smallest.
Operating profit fell from KRW 3.1 billion in 2023 to KRW 1.97 billion in 2024, down 36.6%, and the company posted an operating loss of KRW 6.77 billion in 2025, turning from profit to loss.
For the 2024 decline, the company attributed the increase in cost of sales and selling and administrative expenses to investment in AI solution R&D, hiring of business staff and purchases of research software assets. The operating margin moved from 6.8% in 2023 to 4.1% in 2024 and to -15.5% in 2025.
The 2025 annual operating loss was reported as the first annual loss since 2012. Net income attributable to controlling shareholders was KRW 4.5 billion in 2023 and KRW 2.2 billion in 2024, down 51.2%, and turned into a net loss of KRW 6.83 billion in 2025.
Net income including non-controlling interests was also a net loss of KRW 6.83 billion in 2025. The debt-to-equity ratio rose from 59.5% in 2023 and 44.4% in 2024 to 89.7% in 2025, with total liabilities of KRW 17.4 billion and total equity of KRW 19.3 billion at the end of 2025.
Operating cash flow went from KRW 3.91 billion in 2023 and KRW 3.19 billion in 2024 to -KRW 3.55 billion in 2025. By quarter, the fourth quarter of 2025 was the weakest, with revenue of KRW 7.81 billion, down 38.4% from the prior quarter, and an operating loss of KRW 3.31 billion.
Revenue then rose for three straight quarters from the first quarter of 2026 to the third quarter, reaching KRW 8.68 billion, KRW 9.98 billion and KRW 14.4 billion.
The operating loss narrowed to KRW 799 million in the first quarter and KRW 482 million in the third quarter, but widened to KRW 1.13 billion in the second quarter. Net losses attributable to controlling shareholders over the last four quarters totaled KRW 5.89 billion.